157 related articles for article (PubMed ID: 30085149)
21. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
[TBL] [Abstract][Full Text] [Related]
22. Multiple relapses of Plasmodium vivax malaria acquired from West Africa and association with poor metabolizer CYP2D6 variant: a case report.
He X; Pan M; Zeng W; Zou C; Pi L; Qin Y; Zhao L; Qin P; Lu Y; Baird JK; Huang Y; Cui L; Yang Z
BMC Infect Dis; 2019 Aug; 19(1):704. PubMed ID: 31399061
[TBL] [Abstract][Full Text] [Related]
23. Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.
Morris CA; Lopez-Lazaro L; Jung D; Methaneethorn J; Duparc S; Borghini-Fuhrer I; Pokorny R; Shin CS; Fleckenstein L
Am J Trop Med Hyg; 2012 Mar; 86(3):489-495. PubMed ID: 22403324
[TBL] [Abstract][Full Text] [Related]
24. Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.
Gilder ME; Hanpithakphong W; Hoglund RM; Tarning J; Win HH; Hilda N; Chu CS; Bancone G; Carrara VI; Singhasivanon P; White NJ; Nosten F; McGready R
Clin Infect Dis; 2018 Sep; 67(7):1000-1007. PubMed ID: 29590311
[TBL] [Abstract][Full Text] [Related]
25. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
[TBL] [Abstract][Full Text] [Related]
26. A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Wilairatana P; Silachamroon U; Krudsood S; Singhasivanon P; Treeprasertsuk S; Bussaratid V; Phumratanaprapin W; Srivilirit S; Looareesuwan S
Am J Trop Med Hyg; 1999 Dec; 61(6):973-7. PubMed ID: 10674681
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
29. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
30. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
[TBL] [Abstract][Full Text] [Related]
31. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
[TBL] [Abstract][Full Text] [Related]
32. Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
Phommasone K; van Leth F; Peto TJ; Landier J; Nguyen TN; Tripura R; Pongvongsa T; Lwin KM; Kajeechiwa L; Thwin MM; Parker DM; Wiladphaingern J; Nosten S; Proux S; Nguon C; Davoeung C; Rekol H; Adhikari B; Promnarate C; Chotivanich K; Hanboonkunupakarn B; Jittmala P; Cheah PY; Dhorda M; Imwong M; Mukaka M; Peerawaranun P; Pukrittayakamee S; Newton PN; Thwaites GE; Day NPJ; Mayxay M; Hien TT; Nosten FH; Cobelens F; Dondorp AM; White NJ; von Seidlein L
PLoS One; 2020; 15(2):e0228190. PubMed ID: 32023293
[TBL] [Abstract][Full Text] [Related]
33. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
Pukrittayakamee S; Vanijanonta S; Chantra A; Clemens R; White NJ
J Infect Dis; 1994 Apr; 169(4):932-5. PubMed ID: 8133114
[TBL] [Abstract][Full Text] [Related]
34. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
[TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
Edstein MD; Kocisko DA; Brewer TG; Walsh DS; Eamsila C; Charles BG
Br J Clin Pharmacol; 2001 Dec; 52(6):663-70. PubMed ID: 11736877
[TBL] [Abstract][Full Text] [Related]
36. Lack of sex effect on the pharmacokinetics of primaquine.
Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
Simpson JA; Agbenyega T; Barnes KI; Di Perri G; Folb P; Gomes M; Krishna S; Krudsood S; Looareesuwan S; Mansor S; McIlleron H; Miller R; Molyneux M; Mwenechanya J; Navaratnam V; Nosten F; Olliaro P; Pang L; Ribeiro I; Tembo M; van Vugt M; Ward S; Weerasuriya K; Win K; White NJ
PLoS Med; 2006 Nov; 3(11):e444. PubMed ID: 17132053
[TBL] [Abstract][Full Text] [Related]
38. Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
Kloprogge F; McGready R; Phyo AP; Rijken MJ; Hanpithakpon W; Than HH; Hlaing N; Zin NT; Day NP; White NJ; Nosten F; Tarning J
Br J Clin Pharmacol; 2015 Oct; 80(4):642-53. PubMed ID: 25877779
[TBL] [Abstract][Full Text] [Related]
39. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.
Betuela I; Rosanas-Urgell A; Kiniboro B; Stanisic DI; Samol L; de Lazzari E; Del Portillo HA; Siba P; Alonso PL; Bassat Q; Mueller I
J Infect Dis; 2012 Dec; 206(11):1771-80. PubMed ID: 22966124
[TBL] [Abstract][Full Text] [Related]
40. Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.
Hanboonkunupakarn B; van der Pluijm RW; Hoglund R; Pukrittayakamee S; Winterberg M; Mukaka M; Waithira N; Chotivanich K; Singhasivanon P; White NJ; Dondorp AM; Tarning J; Jittamala P
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
